These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 26639242)
81. The microRNA spectrum in 12 body fluids. Weber JA; Baxter DH; Zhang S; Huang DY; Huang KH; Lee MJ; Galas DJ; Wang K Clin Chem; 2010 Nov; 56(11):1733-41. PubMed ID: 20847327 [TBL] [Abstract][Full Text] [Related]
82. Epigenetic control of autophagy by microRNAs in ovarian cancer. Titone R; Morani F; Follo C; Vidoni C; Mezzanzanica D; Isidoro C Biomed Res Int; 2014; 2014():343542. PubMed ID: 24877083 [TBL] [Abstract][Full Text] [Related]
83. Elevation of serum interleukin-1 receptor antagonist levels in women with gynaecological cancers. Fujiwaki R; Hata T; Miyazaki K; Kawamura T; Inada K Br J Obstet Gynaecol; 1997 Dec; 104(12):1407-8. PubMed ID: 9422021 [TBL] [Abstract][Full Text] [Related]
84. Cellular signaling modulated by miRNA-3652 in ovarian cancer: unveiling mechanistic pathways for future therapeutic strategies. Imran K; Iqbal MJ; Abid R; Ahmad MM; Calina D; Sharifi-Rad J; Cho WC Cell Commun Signal; 2023 Oct; 21(1):289. PubMed ID: 37845675 [TBL] [Abstract][Full Text] [Related]
85. Expression of small heat shock proteins in exosomes from patients with gynecologic cancers. Wyciszkiewicz A; Kalinowska-Łyszczarz A; Nowakowski B; Kaźmierczak K; Osztynowicz K; Michalak S Sci Rep; 2019 Jul; 9(1):9817. PubMed ID: 31285463 [TBL] [Abstract][Full Text] [Related]
86. Electrical Cartridge Sensor Enables Reliable and Direct Identification of MicroRNAs in Urine of Patients. Kim S; Park S; Cho YS; Kim Y; Tae JH; No TI; Shim JS; Jeong Y; Kang SH; Lee KH ACS Sens; 2021 Mar; 6(3):833-841. PubMed ID: 33284011 [TBL] [Abstract][Full Text] [Related]
87. The role of microRNAs in endometrial cancer and influence on future therapy: focusing on miRNA-21. Rak B; Marczewska JM; Wlodarski P Eur J Gynaecol Oncol; 2016; 37(5):599-603. PubMed ID: 29786994 [TBL] [Abstract][Full Text] [Related]
88. Urinary MicroRNAs in Environmental Health: Biomarkers of Emergent Kidney Injury and Disease. Harrill AH; Sanders AP Curr Environ Health Rep; 2020 Jun; 7(2):101-108. PubMed ID: 32166731 [TBL] [Abstract][Full Text] [Related]
89. The relationship of human tissue microRNAs with those from body fluids. Cui C; Cui Q Sci Rep; 2020 Mar; 10(1):5644. PubMed ID: 32221351 [TBL] [Abstract][Full Text] [Related]
90. Evaluation of Somatic Mutations in Urine Samples as a Noninvasive Method for the Detection and Molecular Classification of Endometrial Cancer. Costas L; Onieva I; Pelegrina B; Marin F; Carmona Á; López-Querol M; Frias-Gomez J; Peremiquel-Trillas P; Martínez JM; Dorca E; Brunet J; Pineda M; Ponce J; Matias-Guiu X; de Sanjosé S; Bosch FX; Alemany L; Paytubi S Clin Cancer Res; 2023 Sep; 29(18):3681-3690. PubMed ID: 37439797 [TBL] [Abstract][Full Text] [Related]
91. Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers? Nik Mohamed Kamal NNSB; Shahidan WNS Front Pharmacol; 2019; 10():1500. PubMed ID: 32038230 [TBL] [Abstract][Full Text] [Related]
93. Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer. Xiong J; Fu F; Yu F; He X Discov Oncol; 2023 May; 14(1):65. PubMed ID: 37160813 [TBL] [Abstract][Full Text] [Related]
94. Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Stenman UH; Huhtala ML; Koistinen R; Seppälä M Int J Cancer; 1982 Jul; 30(1):53-7. PubMed ID: 6811446 [TBL] [Abstract][Full Text] [Related]
95. Stability of miRNA in human urine supports its biomarker potential. Mall C; Rocke DM; Durbin-Johnson B; Weiss RH Biomark Med; 2013 Aug; 7(4):623-31. PubMed ID: 23905899 [TBL] [Abstract][Full Text] [Related]
96. Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells. Brasseur K; Fabi F; Adam P; Parent S; Lessard L; Asselin E Oncotarget; 2016 Jun; 7(24):36971-36987. PubMed ID: 27175591 [TBL] [Abstract][Full Text] [Related]
97. Accessible miRNAs as Novel Toxicity Biomarkers. Bailey WJ; Glaab WE Int J Toxicol; 2018; 37(2):116-120. PubMed ID: 29357765 [TBL] [Abstract][Full Text] [Related]
98. Comparison of Serum and Urine as Sources of miRNA Markers for the Detection of Ovarian Cancer. Kupec T; Bleilevens A; Klein B; Hansen T; Najjari L; Wittenborn J; Stickeler E; Maurer J Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760950 [TBL] [Abstract][Full Text] [Related]
99. Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review. Grimaldi AM; Lapucci C; Salvatore M; Incoronato M; Ferrari M Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359288 [TBL] [Abstract][Full Text] [Related]
100. Role of microRNA in Sex Steroid Hormones Signaling and Its Effect in Regulation of Endometrial, Ovarian, and Cervical Cancer: A Literature Review. Fadl J; Aljuhani RA; Albog YH; Khraisat AF; Alsubaie KA Cureus; 2024 Feb; 16(2):e54773. PubMed ID: 38523927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]